Praxis Precision Medicines IncNASDAQ:PRAX
- LAST PRICE69.9900
- TODAY'S CHANGE (%)-0.0350 (-0.0500%)
- Bid / Lots66.5000/ 1
- Ask / Lots73.4500/ 1
- Open / Previous Close70.3700 / 70.0250
- Day Range
- 52 Week Range
- Volume140,819
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PRAX |
|---|---|---|
| 09:32 ET | 3642 | 67.905 |
| 09:34 ET | 300 | 68.745 |
| 09:39 ET | 200 | 69.42 |
| 09:45 ET | 300 | 69.13 |
| 09:52 ET | 107 | 69.335 |
| 09:59 ET | 100 | 69.12 |
| 10:08 ET | 100 | 69.015 |
| 10:10 ET | 150 | 69.07 |
| 10:14 ET | 250 | 69.115 |
| 10:17 ET | 100 | 68.93 |
| 10:21 ET | 100 | 69.11 |
| 10:26 ET | 100 | 69.005 |
| 10:30 ET | 300 | 68.91 |
| 10:32 ET | 300 | 68.88 |
| 10:35 ET | 700 | 68.575 |
| 10:44 ET | 1090 | 68.855 |
| 10:46 ET | 100 | 68.825 |
| 10:50 ET | 100 | 68.885 |
| 10:51 ET | 962 | 69 |
| 11:09 ET | 433 | 68.885 |
| 11:20 ET | 100 | 68.815 |
| 11:22 ET | 200 | 68.77 |
| 11:26 ET | 785 | 68.96 |
| 11:27 ET | 100 | 68.96 |
| 11:29 ET | 100 | 68.96 |
| 11:31 ET | 500 | 68.98 |
| 11:33 ET | 200 | 68.98 |
| 11:49 ET | 300 | 69.31 |
| 12:02 ET | 300 | 69.39 |
| 12:03 ET | 498 | 69.65 |
| 12:14 ET | 100 | 69.685 |
| 12:25 ET | 294 | 70.07 |
| 12:30 ET | 200 | 70.015 |
| 12:38 ET | 300 | 70.06 |
| 12:39 ET | 100 | 69.93 |
| 12:45 ET | 220 | 70.035 |
| 12:48 ET | 400 | 70.22 |
| 12:50 ET | 100 | 70.195 |
| 12:54 ET | 100 | 70.245 |
| 12:57 ET | 100 | 70.28 |
| 01:03 ET | 100 | 70.48 |
| 01:08 ET | 500 | 70.29 |
| 01:10 ET | 11710 | 70.255 |
| 01:12 ET | 3100 | 70.225 |
| 01:14 ET | 350 | 69.98 |
| 01:15 ET | 100 | 69.98 |
| 01:19 ET | 193 | 70.02 |
| 01:30 ET | 100 | 69.88 |
| 01:33 ET | 3792 | 70.485 |
| 01:35 ET | 100 | 70.305 |
| 01:39 ET | 127 | 70.305 |
| 01:57 ET | 200 | 70.15 |
| 02:00 ET | 100 | 70.15 |
| 02:02 ET | 100 | 70.155 |
| 02:04 ET | 200 | 70.1525 |
| 02:08 ET | 100 | 70.15 |
| 02:09 ET | 800 | 70.2 |
| 02:15 ET | 100 | 70.23 |
| 02:18 ET | 200 | 70.2 |
| 02:22 ET | 200 | 70.22 |
| 02:26 ET | 100 | 70.225 |
| 02:27 ET | 400 | 70.2 |
| 02:29 ET | 100 | 70.24 |
| 02:33 ET | 200 | 70.375 |
| 02:40 ET | 200 | 70.46 |
| 02:42 ET | 1000 | 70.45 |
| 02:44 ET | 100 | 70.32 |
| 02:49 ET | 154 | 70.3 |
| 02:54 ET | 200 | 70.47 |
| 03:09 ET | 100 | 70.4 |
| 03:12 ET | 2261 | 70.1 |
| 03:16 ET | 100 | 69.99 |
| 03:18 ET | 387 | 70.18 |
| 03:21 ET | 300 | 69.925 |
| 03:23 ET | 1251 | 69.715 |
| 03:25 ET | 100 | 69.72 |
| 03:30 ET | 900 | 69.59 |
| 03:32 ET | 927 | 69.585 |
| 03:38 ET | 600 | 69.84 |
| 03:41 ET | 200 | 69.7125 |
| 03:45 ET | 628 | 69.835 |
| 03:48 ET | 700 | 69.905 |
| 03:50 ET | 300 | 69.905 |
| 03:52 ET | 1000 | 70.12 |
| 03:54 ET | 3693 | 69.875 |
| 03:56 ET | 3513 | 69.7725 |
| 03:57 ET | 200 | 69.9 |
| 03:59 ET | 40053 | 69.99 |
Yesterday
DJ Praxis Precision Med Is Maintained at Outperform by Oppenheimer, from 10 hours ago by Dow Jones
10 hours ago by Dow Jones
Oct 14, 2024
DJ Longboard Deal Seen Positive for Other DEE Players -- Market Talk, from 11:45AM ET on Monday Oct 14, 2024 by Dow Jones
11:45AM ET on Monday Oct 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Praxis Precision Medicines Inc | 1.2B | -6.8x | --- |
Cassava Sciences Inc | 1.2B | -63.6x | --- |
Upstream Bio Inc | 1.3B | -23.2x | --- |
Kura Oncology Inc | 1.3B | -7.5x | --- |
Cogent Biosciences Inc | 1.3B | -4.6x | --- |
Bicara Therapeutics Inc | 1.2B | -18.9x | --- |
Company Information
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, is an antisense oligonucleotide platform, is an efficient, targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include ulixacaltamide, PRAX-562, PRAX-628 and elsunersen.
Contact Information
- Headquarters
- 99 High Street, 30th FloorBOSTON, MA, United States 02110
- Phone
- 617-300-8460
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Dean Mitchell
- President, Chief Executive Officer, Director
- Marcio Souza
- Chief Financial Officer
- Timothy Kelly
- Vice President - Legal
- Alex Nemiroff
- Independent Director
- Jeffrey Chodakewitz
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
|---|---|
Revenue (TTM) | $1.8M |
Shares Outstanding | 17.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.74 |
EPS | $-10.26 |
Book Value | $7.92 |
P/E Ratio | -6.8x |
Price/Sales (TTM) | 702.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -7,492.72% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
